Cargando…
Identification of novel human receptor activator of nuclear factor-kB isoforms generated through alternative splicing: implications in breast cancer cell survival and migration
INTRODUCTION: The receptor activator of nuclear factor-kB (NF-kB) (RANK)/receptor activator of NF-kB ligand (RANKL) axis emerges as a key regulator of breast cancer initiation, progression and metastasis. RANK receptor is a tumor necrosis superfamily member, which upon ligand binding transduces a va...
Autores principales: | Papanastasiou, Anastasios D, Sirinian, Chaido, Kalofonos, Haralabos P |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3680950/ https://www.ncbi.nlm.nih.gov/pubmed/22824341 http://dx.doi.org/10.1186/bcr3234 |
Ejemplares similares
-
Correction to: Identification of novel human RANK isoforms generated through alternative splicing. Implications in breast cancer cell survival and migration
por: Papanastasiou, Anastasios D., et al.
Publicado: (2018) -
RANK-C Expression Sensitizes ER-Negative, EGFR-Positive Breast Cancer Cells to EGFR-Tyrosine Kinase Inhibitors (TKIs)
por: Sirinian, Chaido, et al.
Publicado: (2021) -
Cellular Senescence in Normal Mammary Gland and Breast Cancer. Implications for Cancer Therapy
por: Sirinian, Chaido, et al.
Publicado: (2022) -
Analysis of RANK-c interaction partners identifies TRAF3 as a critical regulator of breast cancer aggressiveness
por: Sirinian, Chaido, et al.
Publicado: (2022) -
Identification and Characterization of the Alternatively Spliced Nuclear Receptor Coactivator-6 Isoforms
por: Li, Qingtian, et al.
Publicado: (2011)